Clinical Evidence: What the STEP Trials Reveal
How Wegovy Works: The Clinical Trial Evidence You Need
Understanding how Wegovy works requires examining the landmark STEP clinical trials that led to its MHRA approval. In STEP 1, the largest randomised controlled trial, patients taking Wegovy alongside diet and exercise achieved an average weight loss of approximately 15% at 68 weeks, compared to just 2.4% in the placebo group (Wilding et al., NEJM, 2021). This evidence demonstrates that Wegovy's mechanism of action produces clinically significant results when combined with lifestyle modifications. The trial involved 1,961 adults with obesity or overweight with weight-related complications, providing robust data on how Wegovy works in real-world populations.
STEP 3 further validated how Wegovy works when combined with intensive behavioural therapy, showing approximately 16% average weight loss. The SELECT cardiovascular outcomes trial revealed an additional benefit: patients experienced a 20% reduction in major cardiovascular events (HR 0.80), demonstrating that understanding how Wegovy works extends beyond weight management to broader health improvements. These peer-reviewed results form the foundation of NICE TA875 recommendations, confirming that Wegovy works effectively as part of comprehensive weight management programmes.
Wegovy Pricing: Transparent Costs for Proven Results
Our wegovy pricing reflects the clinical evidence behind how Wegovy works, starting with the 0.25mg starter dose at £79.99 after your FIRST40 discount code is applied at checkout. The dose escalation protocol follows clinical trial methodology: 0.5mg costs £94.99, 1mg costs £99.99, 1.7mg costs £139.99, and the 2.4mg maintenance dose costs £209.99. These prices represent the final amount you pay, with discount codes FIRST40 (new customers) or DOSE25 (returning customers) applied automatically at checkout. Understanding how Wegovy works includes recognising that the dose escalation cannot be skipped – each strength serves a specific purpose in optimising tolerance and efficacy.
Our Getting Started bundles provide convenient multi-month supplies based on how Wegovy works through gradual dose increases. The Intro Duo (0.25mg & 0.5mg) costs £169.99, covering your first 8 weeks of treatment. The Progress Trio (0.5mg, 1mg & 1.7mg) costs £369.99, providing 12 weeks of stepped increases. For maintenance therapy, the Ultimate Stability Trio delivers three months of 2.4mg pens for £649.99, ensuring consistent supply once you understand how Wegovy works for your individual response.
How Wegovy Works: The GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormones to regulate appetite and food intake. This prescription-only medicine works by binding to GLP-1 receptors in your brain's appetite control centres, particularly the hypothalamus, reducing hunger signals and promoting satiety after smaller meals. The mechanism behind how Wegovy works also includes slowing gastric emptying, meaning food stays in your stomach longer, contributing to prolonged feelings of fullness. Clinical studies suggest that understanding how Wegovy works involves recognising its effects on food cravings and portion control, rather than simply speeding up metabolism. The once-weekly injection delivers sustained semaglutide levels, maintaining consistent appetite regulation throughout the week. This explains why patients in clinical trials taking Wegovy alongside diet and exercise achieved significant weight management results compared to lifestyle changes alone.
How Wegovy Works: UK Prescribing and Delivery Process
Accessing Wegovy through EverydayMeds begins with a 3-minute online clinical assessment that evaluates your eligibility based on MHRA licensing criteria and NICE guidelines. Our UK-registered prescribers (GPhC #9012878) review your submission within 3 working days (or 24 hours with express service), ensuring Wegovy is appropriate for your individual circumstances. Once approved, your prescription-only medicine is dispensed from our temperature-controlled facility and delivered via next-day cold-chain courier, maintaining the 2-8°C storage requirements essential for semaglutide stability. This process ensures you understand how Wegovy works as part of a medically supervised weight management programme. Our prescribers provide ongoing support, monitoring your progress and adjusting treatment as needed to optimise how Wegovy works for your specific response.
How Wegovy Works: Storage and Practical Administration
Understanding how Wegovy works includes proper storage and administration techniques that maintain its efficacy. Store unopened Wegovy pens in your refrigerator at 2-8°C, though they can remain effective for up to 6 weeks at room temperature below 30°C once removed, providing flexibility for travel. The FlexTouch pen design simplifies weekly injections, with each pen containing 4 doses of your prescribed strength. Rotate injection sites between your thigh, abdomen, or upper arm to prevent lipodystrophy and ensure consistent absorption. The dose escalation schedule cannot be accelerated – your body needs time to adapt to each strength, minimising gastrointestinal side effects while optimising how Wegovy works. Never share pens with others, even if the needle is changed, and dispose of used pens in a sharps container available from any pharmacy.
How Wegovy Works: Long-term Sustainability Evidence
The STEP 5 extension trial provides crucial evidence about how Wegovy works over extended periods, showing sustained weight loss of approximately 15.2% at 104 weeks (2 years). This long-term data demonstrates that understanding how Wegovy works involves recognising its role in maintaining weight loss rather than providing short-term results. Patients who discontinued Wegovy in the STEP 1 extension regained approximately two-thirds of their lost weight within one year, highlighting that weight management represents a chronic condition requiring ongoing treatment.
The SELECT cardiovascular outcomes trial further validates how Wegovy works beyond weight management, showing reduced rates of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke. These results influenced NICE TA875 recommendations, recognising that how Wegovy works encompasses broader health benefits for patients with obesity-related complications. Understanding how Wegovy works therefore involves viewing it as a long-term therapeutic intervention rather than a short-term weight loss solution, supported by the most comprehensive clinical trial programme in obesity medicine.
How Wegovy Works: Real-World UK Clinical Outcomes
Since NICE TA875 approval, real-world evidence continues to validate how Wegovy works in UK clinical practice, with specialist weight management services reporting outcomes consistent with STEP trial results. NHS pilot programmes demonstrate that patients who understand how Wegovy works as part of comprehensive lifestyle interventions achieve optimal results when combined with dietary counselling and physical activity support. The MHRA's additional monitoring status (Black Triangle ▼) ensures ongoing safety surveillance, with adverse events reported through the Yellow Card scheme contributing to our understanding of how Wegovy works across diverse patient populations.
UK prescribing data indicates that patients who achieve the 2.4mg maintenance dose experience the most significant benefits, reinforcing clinical trial evidence about how Wegovy works through adequate dosing. Healthcare providers emphasise that understanding how Wegovy works requires realistic expectations – the 15% average weight loss represents outcomes achieved alongside reduced-calorie diets and increased physical activity, not from medication alone. This real-world context helps patients understand how Wegovy works within broader lifestyle modifications rather than as a standalone intervention.
How Wegovy Works: Getting Started with EverydayMeds
Begin your journey understanding how Wegovy works by completing our comprehensive online assessment at https://everydaymeds.co.uk/collections/wegovy, designed to evaluate your suitability based on current NICE guidelines and MHRA licensing criteria. Use discount code FIRST40 at checkout for new customers or DOSE25 for returning patients – these codes are applied automatically to reach our advertised prices. Our clinical team provides ongoing support to help you understand how Wegovy works for your individual response, with prescriber consultations available throughout your treatment journey. Remember that Wegovy is a prescription-only medicine requiring medical supervision, and our GPhC-registered pharmacy (#9012878) ensures you receive genuine, properly stored medication with full clinical oversight. Start with confidence knowing that our evidence-based approach helps you understand exactly how Wegovy works to support your weight management goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
